ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,824, issued on June 2, was assigned to Montana State University (Bozeman, Mont.).

"Lactococcal expression of IL-35 for treatment of disease" was invented by David Pascual (Gainesville, Fla.) and Massimo Maddaloni (Gainesville, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to therapeutic compositions comprising recombinant bacteria. Further, the disclosure elaborates upon methods of utilizing the herein described therapeutic compositions to treat autoimmune and inflammatory disease. The present teachings also relate to the disclosed recombinant bacteria and methods of producing the recombinant bacteria ut...